Homozygous Rare PARN Missense Mutation in Familial Pulmonary Fibrosis.
作者信息
Zhang David, Zhou Zhengyang, Abu-Hijleh Muhanned, Batra Kiran, Xing Chao, Garcia Christine Kim
机构信息
1 University of Texas Southwestern Medical Center Dallas, Texas.
出版信息
Am J Respir Crit Care Med. 2019 Mar 15;199(6):797-799. doi: 10.1164/rccm.201809-1632LE.
Abstract
摘要
相似文献
1
Homozygous Rare PARN Missense Mutation in Familial Pulmonary Fibrosis.家族性肺纤维化中的纯合罕见PARN错义突变
Am J Respir Crit Care Med. 2019 Mar 15;199(6):797-799. doi: 10.1164/rccm.201809-1632LE.
2
Combined pulmonary fibrosis and emphysema syndrome associated with familial SFTPC mutation.与家族性SFTPC突变相关的合并肺纤维化和肺气肿综合征
Thorax. 2011 Oct;66(10):918-9. doi: 10.1136/thx.2010.151407. Epub 2011 Jan 19.
3
Telomere shortening in familial and sporadic pulmonary fibrosis.家族性和散发性肺纤维化中的端粒缩短
Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37. doi: 10.1164/rccm.200804-550OC. Epub 2008 Jul 17.
4
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis.类风湿关节炎-间质性肺疾病和家族性肺纤维化的共享遗传易感性。
Eur Respir J. 2017 May 11;49(5). doi: 10.1183/13993003.02314-2016. Print 2017 May.
5
Familial Pulmonary Fibrosis and Hermansky-Pudlak Syndrome Rare Missense Mutations in Context.家族性肺纤维化与赫尔曼斯基-普德拉克综合征：相关罕见错义突变情况
Am J Respir Crit Care Med. 2019 Jul 15;200(2):253-256. doi: 10.1164/rccm.201902-0457LE.
6
[Genetic pulmonary fibrosis].
Rev Prat. 2014 Sep;64(7):930-1.
7
Telomerase mutations in families with idiopathic pulmonary fibrosis.特发性肺纤维化家族中的端粒酶突变
N Engl J Med. 2007 Mar 29;356(13):1317-26. doi: 10.1056/NEJMoa066157.
8
[Mode of heredity of familial idiopathic fibrosing alveolitis].
Orv Hetil. 1982 Feb 28;123(9):569.
9
Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis.外显子组测序在一个患有肺纤维化的家族中鉴定出突变的TINF2。
Chest. 2015 May;147(5):1361-1368. doi: 10.1378/chest.14-1947.
10
[Familial diffuse interstitial pulmonary fibrosis].
Med Clin (Barc). 1983 Apr 16;80(13):590-1.
引用本文的文献
1
Germline PARN Variants in Telomere Biology Disorders and Challenges in Variant Curation.端粒生物学障碍中的种系PARN变异及变异整理面临的挑战
Mol Genet Genomic Med. 2025 Jun;13(6):e70107. doi: 10.1002/mgg3.70107.
2
Telomeres: Dysfunction, Maintenance, Aging and Cancer.端粒：功能障碍、维护、衰老和癌症。
Aging Dis. 2023 Nov 29;15(6):2595-2631. doi: 10.14336/AD.2023.1128.
3
The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review.特发性肺纤维化和家族性肺纤维化中的遗传和表观遗传印记：最新综述
Diagnostics (Basel). 2022 Dec 9;12(12):3107. doi: 10.3390/diagnostics12123107.
4
The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group.遗传检测在肺纤维化中的作用：来自肺纤维化基金会遗传检测工作组的观点。
Chest. 2022 Aug;162(2):394-405. doi: 10.1016/j.chest.2022.03.023. Epub 2022 Mar 23.
5
Telomere Dysfunction in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中的端粒功能障碍
Front Med (Lausanne). 2021 Nov 11;8:739810. doi: 10.3389/fmed.2021.739810. eCollection 2021.
6
Familial Pulmonary Fibrosis: Genetic Features and Clinical Implications.家族性肺纤维化：遗传特征与临床意义。
Chest. 2021 Nov;160(5):1764-1773. doi: 10.1016/j.chest.2021.06.037. Epub 2021 Jun 26.
7
Update in Interstitial Lung Disease 2019.2019年间质性肺疾病的进展
Am J Respir Crit Care Med. 2020 Aug 15;202(4):500-507. doi: 10.1164/rccm.202002-0360UP.
8
Familial Interstitial Lung Disease.家族性间质性肺疾病。
Semin Respir Crit Care Med. 2020 Apr;41(2):229-237. doi: 10.1055/s-0040-1708054. Epub 2020 Apr 12.
本文引用的文献
1
Insights from human genetic studies of lung and organ fibrosis.人类肺部和器官纤维化遗传研究的新见解。
J Clin Invest. 2018 Jan 2;128(1):36-44. doi: 10.1172/JCI93556.
2
BCFtools/RoH: a hidden Markov model approach for detecting autozygosity from next-generation sequencing data.BCFtools/RoH：一种用于从新一代测序数据中检测纯合性的隐马尔可夫模型方法。
Bioinformatics. 2016 Jun 1;32(11):1749-51. doi: 10.1093/bioinformatics/btw044. Epub 2016 Jan 30.
3
Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.聚腺苷酸特异性核糖核酸酶（PARN）介导端粒酶RNA组分的3'末端成熟。
Nat Genet. 2015 Dec;47(12):1482-8. doi: 10.1038/ng.3423. Epub 2015 Oct 19.
4
Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN).聚腺苷酸特异性核糖核酸酶（PARN）突变导致的骨髓衰竭和发育迟缓。
J Med Genet. 2015 Nov;52(11):738-48. doi: 10.1136/jmedgenet-2015-103292. Epub 2015 Sep 4.
5
Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.聚腺苷酸特异性核糖核酸酶缺乏会影响端粒生物学并导致先天性角化不良。
J Clin Invest. 2015 May;125(5):2151-60. doi: 10.1172/JCI78963. Epub 2015 Apr 20.
6
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.端粒长度对特发性肺纤维化患者生存的影响：一项具有独立验证的观察性队列研究。
Lancet Respir Med. 2014 Jul;2(7):557-65. doi: 10.1016/S2213-2600(14)70124-9. Epub 2014 Jun 16.
7
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.美国 65 岁及以上医疗保险受益人群中的特发性肺纤维化：2001-2011 年的发病率、患病率和生存率。
Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27.
8
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化：诊断和管理的循证指南（美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布）
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
Zotero 插件